Literature DB >> 1373643

Role of endogenous peptide in human alloreactive cytotoxic T cell responses.

S Man1, R D Salter, V H Engelhard.   

Abstract

The T x B hybrid 174 x CEM.T2 (T2) has been shown to be defective in the processing of proteins for presentation by MHC class I molecules. It continues, however, to express significant quantities of HLA-A2.1, suggesting that this class I molecule is expressed either in a largely peptide-free form or in association with a small subset of peptides. In this paper T2 was used in conjunction with limiting dilution analysis to provide a direct estimate of the fraction of alloreactive cytotoxic T lymphocytes (CTLs) that were dependent upon the presence of peptides for their recognition of HLA-A2.1. Alloreactive cytotoxic T cell lines generated by stimulation with HLA-A2.1 expressing peripheral blood lymphocytes recognized T2 poorly. Split-well analysis of 240 clonal limiting dilution cultures demonstrated that this reflected the existence of two subpopulations. An average 85% of HLA-A2.1 specific CTLs recognized HLA-A2.1 on normal cells but not on T2. The remainder recognized HLA-A2.1 on both T2 and normal targets. CTL lines with the latter specificity could be generated by using T2 as a stimulator cell. Using target cells that either expressed a lower density of HLA-A2.1 or that expressed HLA-A2 molecules that had been mutated to affect CD8 binding, no significant differences in avidity between T2-reactive and T2-unreactive CTLs were seen. Thus the failure of the majority of alloreactive CTLs to recognize T2 is not a consequence of the lower level of HLA-A2.1 surface expression on this cell, but is instead due to the absence of appropriate epitopes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373643     DOI: 10.1093/intimm/4.3.367

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.

Authors:  M H Heemskerk; R A de Paus; E G Lurvink; F Koning; A Mulder; R Willemze; J J van Rood; J H Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

2.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

Authors:  R A Henderson; A L Cox; K Sakaguchi; E Appella; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

3.  A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

Authors:  Qian Yu; Li Zhang; Lichen Ouyang; Yeli Gong; Zhihui Liang; Guanxin Shen; Xiufang Weng; Xiongwen Wu
Journal:  Immunogenetics       Date:  2012-12-12       Impact factor: 2.846

4.  Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease.

Authors:  Juyang Kim; Sohye Park; Hyun-A Kim; Daehee Jung; Hyun Ju Kim; Hye-Jeong Choi; Hong Rae Cho; Byungsuk Kwon
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

Review 5.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

6.  CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.

Authors:  Catherine Matte-Martone; Jinli Liu; Dhanpat Jain; Jennifer McNiff; Warren D Shlomchik
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

7.  Healthy cells functionally present TAP-independent SSR1 peptides: implicattions for selection of clinically relevant antigens.

Authors:  Antonius A de Waard; Tamara Verkerk; Kelly Hoefakker; Dirk M van der Steen; Marlieke L M Jongsma; Dganit Melamed Kadosh; Sophie Bliss; Arnoud H de Ru; Arie Admon; Peter A van Veelen; Marieke Griffioen; Mirjam H M Heemskerk; Robbert M Spaapen
Journal:  iScience       Date:  2021-01-09

8.  TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.

Authors:  A Morita; T Takahashi; E Stockert; E Nakayama; T Tsuji; Y Matsudaira; L J Old; Y Obata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

9.  Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).

Authors:  P A Smith; A Brunmark; M R Jackson; T A Potter
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.